Jefferies Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,169
| Closed | -$436K | – | 1042 |
|
|
2025
Q1 | $436K | Buy |
+6,169
| New | +$436K | ﹤0.01% | 868 |
|
|
2024
Q4 | – | Sell |
-4,350
| Closed | -$306K | – | 1269 |
|
|
2024
Q3 | $306K | Buy |
+4,350
| New | +$306K | ﹤0.01% | 855 |
|
|
2024
Q2 | – | Sell |
-10,600
| Closed | -$926K | – | 1140 |
|
|
2024
Q1 | $926K | Buy |
10,600
+379
| +4% | +$33.1K | 0.01% | 612 |
|
|
2023
Q4 | $986K | Buy |
10,221
+7,231
| +242% | +$697K | 0.01% | 644 |
|
|
2023
Q3 | $265K | Sell |
2,990
-2,023
| -40% | -$179K | ﹤0.01% | 862 |
|
|
2023
Q2 | $435K | Sell |
5,013
-22,904
| -82% | -$1.99M | ﹤0.01% | 822 |
|
|
2023
Q1 | $2.71M | Sell |
27,917
-17,855
| -39% | -$1.74M | 0.02% | 314 |
|
|
2022
Q4 | $4.74M | Buy |
+45,772
| New | +$4.74M | 0.03% | 200 |
|